SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-011431
Filing Date
2018-08-20
Accepted
2018-08-20 16:04:26
Documents
2
Period of Report
2018-08-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k082018b_biondvaxpharma.htm 6-K 21579
2 ARRANGEMENT SIGNED BETWEEN TEL AVIV DISTRICT ATTORNEY AND DR. RON BABECOFF f6k082018bex99-1_biondvax.htm EX-99.1 34588
  Complete submission text file 0001213900-18-011431.txt   57158
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 181028302
SIC: 2836 Biological Products, (No Diagnostic Substances)